Your institution may have access to this item. Find your institution then sign in to continue.
Title
Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity.
Authors
Gneiss, C; Reindl, M; Lutterotti, A; Ehling, R; Egg, R; Khalil, M; Berger, T; Deisenhammer, F
Abstract
It has been reported that in some patients with MS who develop neutralizing antibodies (NAbs) against interferon beta (IFNbeta), antibody levels can initially increase and then decrease thereafter even when treatment is continued.